Aliceblue ANTInstall and trade smarter everywhere
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Gaudium IVF and Women Health Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.
Price Band
₹79
Per ShareLot Size
189 Shares
Minimum Investment
₹14,931
Issue Size
₹165 Cr
Face Value
₹5
Per ShareIPO Type
Book Building
Retail Quota
35%
QIB Quota
50%
NII Quota
15%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
99.98%
Promoter Holding (Post-Issue)
71.3%
Issue Type
Book Building
ISIN
INE0P8B01020
The company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. Gaudium IVF is founded by our Promoter Dr. Manika Khanna, a specialist with advanced training in gynecological endoscopic surgery from Kiel, Germany, and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited. The company operates 30+ locations, which comprises of 7 hubs (centers) and 28 spokes (company has entered into a strategic alliance with Spokes i.e Infertility Expert to achieve the mutual goal of spreading awareness about ART and IVF treatment). Its treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI) and ovulation induction, all its treatment is carefully designed to address a variety of infertility challenges for both male and female.
According to Infomerics Research Report, the global IVF market, valued at USD 27.49 billion in 2024, is projected to double to USD 54.60 billion by 2034 at a CAGR of 7.10%. India's IVF market is set to grow faster, from USD 1.32 billion to USD 4.54 billion over the same period, at a CAGR of 13.13%, expanding its global share from 4.8% to 8.3%. Growth is driven by rising infertility, delayed marriages, lifestyle shifts, and increasing maternal age. Technological advances, regulatory support, and improving access further strengthen adoption. Declining global fertility underscores rising reliance on IVF, positioning India as a key growth hub.
Revenue, profit after tax and total assets across the last 3 reported financial years.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Initial public offering of up to 2,08,86,200 equity shares of face value of Rs. 5.00 each ("Equity Shares") of the company for cash at a price of Rs. 79 per equity share (including a share premium of Rs. 74 per equity share) ("Offer Price") aggregating up to Rs. 165 crores (the "Offer") comprising a fresh issue of up to 1,13,92,500 equity shares of face value of Rs. 5.00 each aggregating up to Rs. 90 crores by the company (the "fresh issue") and an offer for sale of up to 94,93,700 equity shares of face value of Rs. 5.00 each aggregating up to Rs. 75 crores by Manika Khanna, (the "promoter selling shareholder") (the "offer for sale"). The offer would constitute 28.70% of the post-offer paid-up equity share capital of the company. Price Band: Rs. 79 per equity share of face value Rs. 5 /- each. The floor price is 15.8 times of the face value of the equity shares. Bids can be made for a minimum of 189 equity shares and in multiples of 189 equity shares thereafter.
*Subject to approvals and market conditions.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
The Company was originally incorporated in the name of "Gaudium IVF and Women Health Private Limited" as a private limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated March 24, 2015 issued by the RoC, Delhi and Haryana. Subsequently, the Company was converted from a private limited company into a public limited company pursuant to a special resolution passed in the extraordinary general meeting of its Shareholders held on September 28, 2024 and consequently, the name of our Company was changed to `Gaudium IVF and Women Health Limited', and a fresh certificate of incorporation dated October 24, 2024 was issued by the Central processing center.
Wholesaler and Retailer
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a standalone basis, as reported for FY24 to FY26.